Relay Therapeutics, Inc. (RLAY)
Chart Events
Performance Outlook
| Previous Close | 15.00 |
| Open | 15.20 |
| Bid | 15.73 x 800 |
| Ask | 15.75 x 800 |
| Day's Range | 15.00 - 15.85 |
| 52 Week Range | 12.65 - 35.36 |
| Volume | |
| Avg. Volume | 1,261,110 |
| Market Cap | 1.916B |
| Beta (5Y Monthly) | 1.25 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.84 |
| Earnings Date | May 03, 2023 - May 08, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 35.00 |
- GlobeNewswire
Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR
Relay Therapeutics to host conference call following AACR presentationCAMBRIDGE, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that initial clinical data from the ReDiscover trial for RLY-2608 have been selected for presentation at the upcoming American Association for Cancer Research (AACR)
- GlobeNewswire
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in two fireside chats this month, at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 10:30 a.m. ET and the Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 4:05 p.m. ET. The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following
- Simply Wall St.
Relay Therapeutics Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag
Relay Therapeutics ( NASDAQ:RLAY ) Full Year 2022 Results Key Financial Results Net loss: US$290.5m (loss narrowed by...
